Dexmedetomidine hydrochloride
Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride is a prescription injectable solution used for short-term sedation in intensive care settings. It works as an alpha-2 adrenergic agonist to provide calming effects during procedures or mechanical ventilation. Administered intravenously at 4 mcg/mL strength in 50 mL or 100 mL bottles, it's approved as a generic drug by Sagent Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride is a prescription injectable solution used for short-term sedation in intensive care settings. It works as an alpha-2 adrenergic agonist to provide calming effects during procedures or mechanical ventilation. Administered intravenously at 4 mcg/mL strength in 50 mL or 100 mL bottles, it's approved as a generic drug by Sagent Pharmaceuticals. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Dexmedetomidine hydrochloride",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Dexmedetomidine hydrochloride — ANDA 209307 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209307"
}
]
|
| identifier | ANDA209307 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-safety",
"health-care",
"medications"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Dexmedetomidine hydrochloride |
